Vancouver
Ito K, Ohe M, Shida H, Nagai K, Furuya K, Okamoto T. Multiple myeloma diagnosed by flow cytometry plotting of CD19-positive and negative plasma cells. J CLIN EXP INVEST. 2022;13(4):em00802. https://doi.org/10.29333/jcei/12374
APA
Ito, K., Ohe, M., Shida, H., Nagai, K., Furuya, K., & Okamoto, T. (2022). Multiple myeloma diagnosed by flow cytometry plotting of CD19-positive and negative plasma cells. Journal of Clinical and Experimental Investigations, 13(4), em00802. https://doi.org/10.29333/jcei/12374
AMA
Ito K, Ohe M, Shida H, Nagai K, Furuya K, Okamoto T. Multiple myeloma diagnosed by flow cytometry plotting of CD19-positive and negative plasma cells. J CLIN EXP INVEST. 2022;13(4), em00802. https://doi.org/10.29333/jcei/12374
Chicago
Ito, Koya, Masashi Ohe, Haruki Shida, Katsura Nagai, Ken Furuya, and Tetsuro Okamoto. "Multiple myeloma diagnosed by flow cytometry plotting of CD19-positive and negative plasma cells". Journal of Clinical and Experimental Investigations 2022 13 no. 4 (2022): em00802. https://doi.org/10.29333/jcei/12374
Harvard
Ito, K., Ohe, M., Shida, H., Nagai, K., Furuya, K., and Okamoto, T. (2022). Multiple myeloma diagnosed by flow cytometry plotting of CD19-positive and negative plasma cells. Journal of Clinical and Experimental Investigations, 13(4), em00802. https://doi.org/10.29333/jcei/12374
MLA
Ito, Koya et al. "Multiple myeloma diagnosed by flow cytometry plotting of CD19-positive and negative plasma cells". Journal of Clinical and Experimental Investigations, vol. 13, no. 4, 2022, em00802. https://doi.org/10.29333/jcei/12374